Skip to main content
Article thumbnail
Location of Repository

Identification, Design and Biological Evaluation of Heterocyclic Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)

By Suet C. Leung, Peter Gibbons, Richard Amewu, Gemma L. Nixon, Chandrakala Pidathala, W. David Hong, Bénédicte Pacorel, Neil G. Berry, Raman Sharma, Paul A. Stocks, Abhishek Srivastava, Alison E. Shone, Sitthivut Charoensutthivarakul, Lee Taylor, Olivier Berger, Alison Mbekeani, Alasdair Hill, Nicholas E. Fisher, Ashley J. Warman, Giancarlo A. Biagini, Stephen A. Ward and Paul M. O’Neill
Topics:
Publisher: American Chemical Society
OAI identifier: oai:pubmedcentral.nih.gov:3351724
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
    2. (2009). Chapter 17 Type II NADH: quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assays. Methods Enzymol.
    3. (2005). Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation.
    4. (2009). Fact sheet Number 94; World Health Organization:
    5. (2006). Functional characterization and target validation of alternative complex I of Plasmodium falciparum mitochondria. Antimicrob. Agents Chemother.
    6. (1976). Human malaria parasites in continuous culture.
    7. (2012). Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum Type II NADH:quinone oxidoreductase
    8. Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors.
    9. (2010). Phosphate ester of a 4-pyridone derivative and its use in the chemotherapy of parasitic infections.
    10. (2006). Reoptimization of MDL keys for use in drug discovery.
    11. (2004). Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother.
    12. Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains.
    13. (2006). The novel reaction of ketones with o-oxazoline-substituted anilines. Tetrahedron
    14. (2001). The past, present and future of childhood malaria mortality in Africa. Trends Parasitol.
    15. (2011). The state of the art in anti-malarial drug discovery and development.
    16. XP13512 [(±)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.